- Both the companies are collaborating to develop mRNA-3351
- CN-1is a rare disease caused due to mutation in gene UGT1A1
The Institute for Life Changing Medicines (ILCM) and the Moderna have announced their collaboration, to develop a new mRNA therapeutic for Crigler-Najjar Syndrome Type-1 (CN-1).
CN-1 is an ultra-rare disease, and there are only 70-1....
Tags : MOderna, Gene, Mutation, CN-1, UGT1A1,